• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类血小板与玻璃之间的一些相互作用:血管性血友病与正常情况的比较。

Some interactions between human platelets and glass: von Willebrand's disease compared with normal.

作者信息

O'Brien J R, Heywood J B

出版信息

J Clin Pathol. 1967 Jan;20(1):56-64. doi: 10.1136/jcp.20.1.56.

DOI:10.1136/jcp.20.1.56
PMID:5297360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC473421/
Abstract

If native or heparinized blood is passed slowly through a column of glass beads at room temperature, the number of platelets removed from the initial drop emerging from the column is less than that removed from the final drop. At 4 degrees C. this difference disappears. If the blood is passed rapidly through such columns at room temperature fewer platelets are removed, but the initial-final difference persists. Von Willebrand's platelets are removed normally at slow speeds; at fast speeds abnormally few platelets are removed. Platelets emerging from all such columns are in aggregates. On adding glass beads to normal heparinized plasma, the platelets at once become more rounded and after about 50 seconds' delay they aggregate: the delay and rate of aggregation can be quantitated. Aggregation occurs best at 20 to 30 degrees C. and is not inhibited by the addition of some enzyme inhibitors. In von Willebrand's disease all these glass-induced aggregation phenomena occur normally and aggregation in response to adenosine diphosphate (ADP), serotonin creatinine sulphate (5-HT), adrenaline, collagen, and glass is also normal.

摘要

如果将未处理的或肝素化的血液在室温下缓慢通过一列玻璃珠,从柱中流出的最初一滴血液中被去除的血小板数量比最后一滴中的少。在4摄氏度时,这种差异消失。如果血液在室温下快速通过此类柱,则被去除的血小板较少,但最初与最后的差异仍然存在。血管性血友病患者的血小板在慢速时正常被去除;在快速时被异常少量地去除。从所有此类柱中流出的血小板都聚集成团。向正常肝素化血浆中加入玻璃珠后,血小板立即变得更圆,约50秒后延迟聚集:这种延迟和聚集速率可以定量。聚集在20至30摄氏度时最佳,并且不受某些酶抑制剂添加的抑制。在血管性血友病中,所有这些玻璃诱导的聚集现象都正常发生,并且对二磷酸腺苷(ADP)、5-羟色胺硫酸肌酐(5-HT)、肾上腺素、胶原蛋白和玻璃的聚集反应也正常。

相似文献

1
Some interactions between human platelets and glass: von Willebrand's disease compared with normal.人类血小板与玻璃之间的一些相互作用:血管性血友病与正常情况的比较。
J Clin Pathol. 1967 Jan;20(1):56-64. doi: 10.1136/jcp.20.1.56.
2
Platelet deposition on von Willebrand factor-deficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized blood.血小板在血管性血友病因子缺乏的血管上的沉积。使用天然血液和肝素化血液对患有血管性血友病的猪进行体外灌注研究。
J Lab Clin Med. 1987 Nov;110(5):634-47.
3
Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.与瑞斯托霉素诱导的血小板聚集相关的血小板膜糖蛋白。对伯纳德-苏利耶综合征和血管性血友病患者血小板上蛋白质的研究。
J Clin Invest. 1976 Jan;57(1):112-24. doi: 10.1172/JCI108251.
4
Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome.剪切速率对枸橼酸化血液和全血中血小板与内皮下层相互作用的影响。I. 剪切速率依赖性降低血管性血友病和伯-苏综合征中的黏附作用。
J Lab Clin Med. 1978 Nov;92(5):750-64.
5
Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.血管性血友病中瑞斯托霉素诱导的血小板聚集缺陷及其通过因子VIII的纠正。
J Clin Invest. 1973 Nov;52(11):2697-707. doi: 10.1172/JCI107464.
6
Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.正常受试者及血管性血友病患者血小板结合的瑞斯托菌素聚集因子
J Lab Clin Med. 1976 Jun;87(6):976-86.
7
Decreased platelet adhesion on vessel segments in von Willebrand's disease: a defect in initial platelet attachment.血管性血友病患者血管段上血小板黏附减少:初始血小板附着缺陷。
J Lab Clin Med. 1983 Oct;102(4):551-64.
8
The effect of ionophore on platelet aggregation in von Willebrand's disease and in congenital afibrinogenemia. A comparison with ristocetin.离子载体对血管性血友病和先天性无纤维蛋白原血症中血小板聚集的影响。与瑞斯托菌素的比较。
Acta Haematol. 1976;56(3):151-9. doi: 10.1159/000207932.
9
Fibronectin in von Willebrand's disease and thrombasthenia: role in platelet aggregation.
J Lab Clin Med. 1981 Jan;97(1):134-40.
10
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.对血管性血友病中缺乏的、血小板聚集所必需的一种血浆因子进行定量测定。与凝血因子VIII促凝活性及抗原含量的关系。
J Clin Invest. 1973 Nov;52(11):2708-16. doi: 10.1172/JCI107465.

引用本文的文献

1
Platelet Aggregation Tests and Thrombosis.血小板聚集试验与血栓形成
J R Coll Physicians Lond. 1969 Jan;3(2):193-200.
2
Decreased platelet function in aortic valve stenosis: high shear platelet activation then inactivation.主动脉瓣狭窄时血小板功能降低:高剪切力下血小板先激活后失活。
Br Heart J. 1995 Dec;74(6):641-4. doi: 10.1136/hrt.74.6.641.
3
Estimation of platelet adhesiveness on whole blood and platelet-rich plasma.全血和富血小板血浆中血小板黏附性的评估。
J Clin Pathol. 1970 Mar;23(2):144-8. doi: 10.1136/jcp.23.2.144.
4
Von Willebrand factor and platelet adhesiveness.血管性血友病因子与血小板黏附性。
J Clin Pathol. 1970 Apr;23(3):228-31. doi: 10.1136/jcp.23.3.228.

本文引用的文献

1
[Phase contrast microscopy; applications to hematology].[相差显微镜术;在血液学中的应用]
Rev Hematol. 1949;4(3):481-501.
2
VON WILLEBRAND'S DISEASE: USE OF A PLATELET-ADHESIVENESS TEST IN DIAGNOSIS AND FAMILY INVESTIGATION.血管性血友病:血小板黏附试验在诊断及家系调查中的应用
N Engl J Med. 1965 Jul 22;273:171-81. doi: 10.1056/NEJM196507222730401.
3
MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE.血小板黏附性的测定。一种显示血管性血友病异常的简单体外技术。
J Lab Clin Med. 1963 Nov;62:724-35.
4
In vitro abnormality of the blood in von Willebrand's disease correctable by normal plasma.
Nature. 1963 Feb 9;197:601-2. doi: 10.1038/197601a0.
5
Aggregation of blood platelets by adenosine diphosphate and its reversal.二磷酸腺苷引起的血小板聚集及其逆转
Nature. 1962 Jun 9;194:927-9. doi: 10.1038/194927b0.
6
The adhesiveness of native platelets and its prevention.天然血小板的黏附性及其预防。
J Clin Pathol. 1961 Mar;14(2):140-9. doi: 10.1136/jcp.14.2.140.
7
Changes in platelet volume produced by temperature, metabolic inhibitors, and aggregating agents.
Proc Soc Exp Biol Med. 1965 Nov;120(2):296-301. doi: 10.3181/00379727-120-30516.